Autologous hematopoietic cell transplantation (HCT) for non-Hodgkin lymphoma (NHL) in patients over 60 years of age

20620 Background: High dose chemotherapy followed by autologous HCT is the treatment of choice for relapsed NHL. Safety and efficacy in elderly patients has not been adequately studied. Methods: Th...